Lo-Femenal: Combined oral contraceptive
Lo-Femenal is a combined oral contraceptive intended to prevent pregnancy. It consists of two active components: norgestrel and ethinyl estradiol. The dosage form of Lo-Femenal is tablets, which are manufactured by Biochemi GmbH in Austria and Waeth-Lederle in the United States of America.
The combination of norgestrel and ethinyl estradiol provides effective contraception by suppressing ovulation, altering the cervical lining and preventing implantation of a fertilized egg. Lo-Femenal is one of the synonyms for this combined oral contraceptive and can also be sold under the names Ovidon, Rigevidon, Rigevidon 21+7 and Stediril-D.
Before you start using Lo-Femenal, you need to familiarize yourself with the contraindications. This drug is not recommended in the presence of tumors, a tendency to thromboembolism, otosclerosis, liver cirrhosis, hepatitis, cholecystitis, chronic colitis and diseases of the endocrine glands. It is important to pay attention to these contraindications and consult a doctor before starting to take Lo-Femenal.
Like any other medicine, Lo-Femenal may cause some side effects. These may include nausea, weight gain, breast tenderness and dyspeptic symptoms. If you experience any side effects while using Lo-Femenal, it is recommended that you consult your doctor.
There is no data on the interaction of Lo-Femenal with other drugs. However, it is always recommended to tell your doctor about all medications you are taking to avoid possible unwanted interactions.
There is no information on overdose and special instructions for the use of Lo-Femenal. In case of accidental overdose or any unusual reactions to taking the drug, you should seek medical help.
Lo-Femenal is one of the combined oral contraceptives that are widely used to prevent pregnancy. However, before you start using Lo-Femenal, you should consult with your doctor to ensure that it is safe and suitable for your individual health.
Literature:
- Directory "Medicinal Medicinal Medicinal-Femenal: Effective combined oral contraceptive
Lo-Femenal is a combined oral contraceptive designed to prevent pregnancy. The manufacturers of this drug are Biochemi GmbH from Austria and Waeth-Lederle from the United States of America. It belongs to the pharmacological group of combined oral contraceptives.
The main components of Lo-Femenal are ethinyl estradiol and norgestrel. These active ingredients provide highly effective contraception. The dosage form of Lo-Femenal is tablets that are taken orally.
The main indications for the use of Lo-Femenal are the prevention of pregnancy. It can be used as a reliable method of contraception when used correctly and regularly. Taking Lo-Femenal is recommended only after consulting a doctor.
Lo-Femenal has some contraindications. It is not recommended in the presence of tumors, a tendency to thromboembolism, otosclerosis, liver cirrhosis, hepatitis, cholecystitis, chronic colitis and diseases of the endocrine glands. Before starting to take Lo-Femenal, it is important to inform your doctor about all existing contraindications and medical history.
In some cases, side effects may occur when using Lo-Femenal. Some of them include nausea, weight gain, breast tenderness and diarrhea. If you experience any side effects, you should contact your doctor for advice.
Information on the interaction of Lo-Femenal with other drugs is limited. However, it is always recommended to tell your doctor about all medications you take to avoid possible unwanted interactions.
According to the literature, there is no information on overdose and special instructions for the use of Lo-Femenal. If you have any problems or questions about the drug, you should contact your healthcare professional or pharmacist.
Lo-Femenal is one of the combined oral contraceptives available in the market. It is highly effective in preventing pregnancy when used correctly. However, before you start using Lo-Femenal, you should consult your doctor and read the instructions for use.
Literature:
- Directory "Medicines", under p.